Viking Therapeutics, Inc. (VKTX) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 608.21M | 715.6M | 738.7M | 827.02M | 866.02M | 907.22M | 936.65M | 945.72M | 966.34M | 367.23M | 381.3M | 399.37M | 149.47M | 167.04M | 165.15M | 179.86M | 193.3M | 210.53M | 224.28M | 237.66M |
| Cash & Short-Term Investments | 602.96M | 705.74M | 714.57M | 807.72M | 851.86M | 902.61M | 930.44M | 942.26M | 962.98M | 362.08M | 376.24M | 392.92M | 135.66M | 155.49M | 155.02M | 168.92M | 184.9M | 202.1M | 216.13M | 228.26M |
| Cash Only | 118.12M | 165.81M | 100.38M | 33.88M | 37.94M | 26.68M | 50.35M | 43.91M | 195.58M | 55.52M | 37.19M | 69.52M | 18.36M | 36.63M | 29.41M | 16.23M | 12.45M | 26.37M | 11.26M | 8.83M |
| Short-Term Investments | 484.85M | 539.93M | 614.19M | 773.84M | 813.92M | 875.94M | 880.09M | 898.35M | 767.4M | 306.56M | 339.06M | 323.4M | 117.3M | 118.85M | 125.61M | 152.69M | 172.44M | 175.73M | 204.87M | 219.43M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.22M | 1.81M | 2.24M | 19.29M | 13.3M | 1.13M | 1.73M | 3.32M | 2.72M | 2.52M | 4.39M | 5.49M | 3.93M | 8.14M | 9.17M | 9.86M | 8.01M | 7.81M | 7.24M | 8.25M |
| Total Non-Current Assets | 33K | 131K | 712K | 834K | 970K | 1.1M | 1.24M | 1.11M | 1.18M | 1.26M | 1.36M | 1.32M | 1.43M | 1.49M | 1.54M | 1.65M | 1.73M | 134K | 189K | 183K |
| Property, Plant & Equipment | 0 | 85K | 666K | 780K | 892K | 1M | 1.11M | 977K | 1.05M | 1.13M | 1.2M | 1.27M | 1.35M | 1.42M | 1.49M | 1.56M | 1.63M | 25K | 101K | 176K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 33K | 46K | 46K | 54K | 78K | 102K | 126K | 138K | 131K | 139K | 163K | 49K | 81K | 71K | 48K | 85K | 97K | 109K | 88K | 7K |
| Total Assets | 608.24M | 715.73M | 739.41M | 827.85M | 866.99M | 908.32M | 937.89M | 946.84M | 967.52M | 368.49M | 382.66M | 400.69M | 150.9M | 168.53M | 166.68M | 181.51M | 195.03M | 210.66M | 224.47M | 237.84M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -29.84% | -21.2% | -21.16% | -12.57% | -10.39% | 146.5% | 145.09% | 136.3% | 541.19% | 118.65% | 129.58% | 120.76% | -22.63% | -20% | -25.75% | -23.69% | -22.03% | -17.87% | -14.85% | -12.3% |
| Total Current Liabilities | 106.33M | 76.67M | 26.07M | 31.98M | 19.57M | 27.41M | 25.68M | 25.09M | 32.77M | 19.14M | 13.4M | 13.48M | 15.65M | 21.95M | 14.06M | 14.86M | 11.27M | 8.78M | 11.35M | 12.87M |
| Accounts Payable | 67.18M | 53.25M | 4.41M | 5.49M | 7.7M | 9.81M | 254K | 11.09M | 5.22M | 7.51M | 5.71M | 5.61M | 3.8M | 8.53M | 3.14M | 6.1M | 3.12M | 1.44M | 2.85M | 4.21M |
| Days Payables Outstanding | - | 28.22K | 4K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 480K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 39.14M | 0 | 0 | 0 | 0 | 0 | 24.95M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 5.72x | 9.33x | 28.34x | 25.86x | 44.25x | 33.09x | 36.47x | 37.69x | 29.48x | 19.19x | 28.44x | 29.63x | 9.55x | 7.61x | 11.74x | 12.10x | 17.15x | 23.98x | 19.76x | 18.46x |
| Quick Ratio | 5.72x | 9.33x | 28.34x | 25.86x | 44.25x | 33.09x | 36.47x | 37.69x | 29.48x | 19.19x | 28.44x | 29.63x | 9.55x | 7.61x | 11.74x | 12.10x | 17.15x | 23.98x | 19.76x | 18.46x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 318K | 410K | 502K | 630K | 755K | 766K | 852K | 936K | 1.02M | 1.1M | 1.18M | 1.26M | 1.34M | 1.41M | 1.49M | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 318K | 410K | 502K | 630K | 755K | 766K | 852K | 936K | 1.02M | 1.1M | 1.18M | 1.26M | 1.34M | 1.41M | 1.49M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 106.33M | 76.67M | 26.39M | 32.39M | 20.07M | 28.04M | 26.44M | 25.86M | 33.63M | 20.07M | 14.42M | 14.58M | 16.83M | 23.21M | 15.4M | 16.28M | 12.76M | 8.78M | 11.35M | 12.87M |
| Total Debt | 0 | 137K | 755K | 878K | 1M | 1.12M | 1.24M | 1.1M | 1.18M | 1.26M | 1.34M | 1.41M | 1.49M | 1.56M | 1.64M | 1.65M | 1.64M | 29K | 115K | 198K |
| Net Debt | -118.12M | -165.67M | -99.62M | -33M | -36.94M | -25.56M | -49.11M | -42.81M | -194.4M | -54.26M | -35.85M | -68.11M | -16.87M | -35.07M | -27.77M | -14.57M | -10.81M | -26.34M | -11.15M | -8.63M |
| Debt / Equity | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | -12320.13x | -3107.25x | -2311.21x | -1926.58x | -1523.17x | -1891.89x | -1216.89x | -1126.35x | -13632.50x | -741.88x | -733.46x | -2535.38x | -599.85x | -1469.25x | - | -1042.50x | - | -740.05x |
| Total Equity | 501.92M | 639.06M | 713.03M | 795.46M | 846.92M | 880.28M | 911.45M | 920.98M | 933.89M | 348.42M | 368.24M | 386.12M | 134.06M | 145.32M | 151.28M | 165.23M | 182.27M | 201.88M | 213.12M | 224.97M |
| Equity Growth % | -40.74% | -27.4% | -21.77% | -13.63% | -9.31% | 152.65% | 147.51% | 138.52% | 596.6% | 139.76% | 143.41% | 133.68% | -26.45% | -28.02% | -29.01% | -26.56% | -23.17% | -17.38% | -16.03% | -14.11% |
| Book Value per Share | 4.34 | 5.61 | 6.35 | 7.09 | 7.56 | 7.91 | 8.22 | 8.34 | 9.03 | 3.48 | 3.69 | 3.90 | 1.71 | 1.90 | 1.98 | 2.15 | 2.35 | 2.63 | 2.73 | 2.89 |
| Total Shareholders' Equity | 501.92M | 639.06M | 713.03M | 795.46M | 846.92M | 880.28M | 911.45M | 920.98M | 933.89M | 348.42M | 368.24M | 386.12M | 134.06M | 145.32M | 151.28M | 165.23M | 182.27M | 201.88M | 213.12M | 224.97M |
| Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K |
| Retained Earnings | -1.01B | -847.55M | -689.88M | -599.1M | -533.54M | -487.91M | -452.49M | -427.55M | -405.3M | -377.94M | -353.34M | -330.81M | -311.58M | -292.05M | -272.49M | -256.72M | -239.28M | -223.18M | -210.83M | -197.58M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.79M | -6.79M | -6.79M | -6.79M | -6.79M | -6.79M | -6.79M | -5.12M | 0 | 0 | 0 |
| Accumulated OCI | -856K | 378K | 374K | -166K | -216K | -788K | 1.63M | -2.27M | -1.6M | -389K | -905K | -1.04M | -618K | -1.1M | -1.76M | -1.65M | -1.41M | -549K | -170K | -189K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |